January 26, 2021
Business News

Shareholder Alert: Robbins LLP Announces that Odonate Therapeutics, Inc. (ODT) is Being Sued for Misleading Shareholders

SAN DIEGO–()–Shareholder rights law firm Robbins LLP announces that a purchaser of securities of Odonate Therapeutics, Inc. (NASDAQ: ODT) has filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between December 7, 2017 and August 21, 2020. Based in San Diego, California, Odonate is a pharmaceutical company that develops therapeutics for the treatment of cancer. The Company is developing tesetaxel, an oral chemotherapy.

If you suffered a loss due to Odonate Therapeutics, Inc.’s misconduct, click here.

Odonate Therapeutics, Inc. (ODT) Accused of Misrepresenting Potential of New Cancer Drug

According to the complaint, during the relevant period, Odonate…

Click here to view the original article.

Related Posts

You might also like ...

Orchid Island Capital to Announce Fourth Quarter 2020 Results
StreamSets Recognized by insideBIGDATA Impact 50 List and Wealthfront’s 2021 Career-Launching Companies List as Top Player in Data and Employment Spaces
Allurion Technologies bringt Virtual Care Suite auf den Markt, um die Erfahrung von Verbrauchern und Anbietern neu zu gestalten